Serum levels of arginase I are associated with left ventricular function after myocardial infarction
| Autor: | Yesim Unlucerci, Seldag Bekpinar, Akar Yilmaz, Seval Develi, Figen Gurdol |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
medicine.medical_specialty
Homocysteine Arginine Clinical Biochemistry Myocardial Infarction Ventricular Function Left Nitric oxide chemistry.chemical_compound Downregulation and upregulation Internal medicine medicine Humans Myocardial infarction Ejection fraction Arginase business.industry Stroke Volume General Medicine medicine.disease Endocrinology chemistry Case-Control Studies Cardiology business Asymmetric dimethylarginine |
| Zdroj: | Clinical Biochemistry. 44:1090-1093 |
| ISSN: | 0009-9120 |
| Popis: | Objectives Upregulation of arginase redirects the arginine metabolism from nitric oxide (NO) synthesis to the formation of polyamine and proline, thus causing cardiac dysfunction. NO synthesis is also impaired by asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor. We aimed to evaluate the impact of arginase and ADMA levels on left ventricular function after myocardial infarction (MI). Design and methods Blood samples from 43 MI patients and 33 controls were used. Arginase I and TNF-α were quantified by ELISA; arginine, ADMA and homocysteine concentrations by HPLC; and high-sensitive CRP by immunoassay techniques. Results Arginase concentrations were higher in MI patients than in controls (121 ± 73 ng/mL vs 58 ± 41, p = 0.001) and were negatively associated with left ventricular ejection fraction (r = − 0.467, p = 0.019). Significantly low arginine/ADMA ratio was observed in MI patients. Conclusion Induced arginase I after myocardial infarction may deplete the arginine pool. The changes related to arginine metabolism may have a role in ventricular dysfunction. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect